医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
苯二酰亚氨乙醛二乙基乙缩醛 | 4'-(furan-2-yl)-2,2':6',2''-terpyridine | 375382-77-7 | C19H13N3O |
|
苯二甲酰亚氨基乙醛 | N-phthalimidyl-2-aminoacetaldehyde | 2913-97-5 | C10H7NO3 |
|
苯丙酸,b-羟基-a-亚甲基-,甲基酯,(R)- | methyl (R)-3-hydroxy-3-phenyl-2-methylenepropanoate | 18020-59-2 | C11H12O3 |
|
苯丙酸,b-羟基-a-亚甲基-,甲基酯,(R)- | methyl (S)-3-hydroxy-3-phenyl-2-methylenepropanoate | 18020-59-2 | C11H12O3 |
|
苝二酰亚胺-吡啶 | N,N'-Di(4-pyridyl)-1,6,7,12-tetra(4-tert-butylphenoxy)perylene-3,4:9,10-tetracarboxylic acid bisimide | 266678-68-6 | C74H64N4O8 |
|
苏型-(2RS)-4-苯基-3-乙酰氨基-2-羟基-4-氧代丁酸 | 2-benzyloxycarbonylsulfanyl-4,6-dimethyl-pyrimidine | 42116-21-2 | C14H14N2O2S |
|
苄基辛基己二酸酯 | Benzyl octyl adipate | 3089-55-2 | C21H32O4 |
|
苄基溴-d7 | perdeuteriobenzyl bromide | 35656-93-0 | C7H7Br |
|
苄基异丁基甲醇 | 4-methyl-1-phenylpentan-2-ol | 7779-78-4 | C12H18O |
|
苄基吡啶-2-基甲胺 | 2-(N-benzylaminomethyl)pyridine | 18081-89-5 | C13H14N2 |
|
苄基2-脱氧-2-邻苯二甲酰亚胺基-3,4,6-三-O-乙酰基-beta-D-吡喃葡萄糖苷 | benzyl 3,4,6-tri-O-acetyl-2-phthalimido-2-deoxy-β-D-glucopyranoside | 80035-31-0 | C27H27NO10 |
|
苄基2-叠氮基-3,6-二-O-苄基-2-脱氧-Β-D-吡喃葡萄糖苷 | benzyl 2-azido-3,6-di-O-benzyl-2-deoxy-β-D-glucopyranoside | 342640-42-0 | C27H29N3O5 |
|
苄基2,4-二(苄氧基)-6-氯-5-乙基烟酸酯 | benzyl 2,4-bis(benzyloxy)-6-chloro-5-ethylnicotinate | 1426530-29-1 | C29H26ClNO4 |
|
苄基-Β-L-吡喃阿拉伯糖苷 | benzyl β-L-arabinopyranoside | 7473-38-3 | C12H16O5 |
|
苄基-11氢吡咯并[3,4-B]吡啶 | 6-benzyloctahydro-1H-pyrrolo[3,4-b]pyridine | 128740-14-7 | C14H20N2 |
|
苄基(5-氧代四氢-3-呋喃基)氨基甲酸酯 | (R,S)-4-benzyloxycarbonylamino-4,5-dihydro-2(3H)-furanone | 305859-68-1 | C12H13NO4 |
|
苄基 2-(乙酰氨基)-2-脱氧-6-O-(苯基甲基)-3-O-2-丙烯-1-基-alpha-D-吡喃葡萄糖苷 | benzyl 2-acetamido-3-O-allyl-6-O-benzyl-2-deoxy-α-D-glucopyranoside | 60920-82-3 | C25H31NO6 |
|
苄哒唑 | benznidazole | 22994-85-0 | C12H12N4O3 |
|
芸香碱 | graveoline | 485-61-0 | C17H13NO3 |
|
芴甲氧羰基-L-缬氨酰-L-丙氨酸 | N-(9-fluorenylmethoxycarbonyl)-L-valyl-L-alanine | 150114-97-9 | C23H26N2O5 |
|
芴丁酯 | 9-hydroxy-9-fluorene carboxylic acid | 467-69-6 | C14H10O3 |
|
花椒毒醇 | 8-hydroxypsoralen | 2009-24-7 | C11H6O4 |
|
芬地柞酸 | 2-<(2'-hydroxy-5'-biphenylyl)carbonyl>benzoic acid | 84627-04-3 | C20H14O4 |
|
艾莎康唑中间体 | (2R,3R)-2-(2,5-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol | 241479-72-1 | C12H13F2N3O2 |
|
艾瑞芬净 | ibrexafungerp | 1207753-03-4 | C44H67N5O4 |
|
艾沙康唑中间体7 | (2S,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | 241479-74-3 | C13H12F2N4O |
|
艾沙康唑中间体6 | (2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanamide | 241479-75-4 | C13H14F2N4O2 |
|
艾氟康唑中间体2 | 1-[(2R,3R)-2-(2,4-difluorophenyl)-2,3-dihydroxybutyl]-1H-[1,2,4]triazole methanesulfonate salt | 1175536-50-1 | CH4O3S*C12H13F2N3O2 |
|
艾日布林中间体 | 3-((2S,5S)-5-(2-((2S,4R,6R)-6-(((2S,3S,4R,5R)-5-((S)-2,3-bis((tert-butyldimethylsilyl)oxy)propyl)-4-methoxy-3-((phenylsulfonyl)methyl)tetrahydrofuran-2-yl)methyl)-4-methyl-5-methylenetetrahydro-2H-pyran-2-yl)ethyl)-4-methylenetetrahydrofuran-2-yl)propan-1-ol | 253128-10-8 | C45H78O9SSi2 |
|
艾地骨化醇90A-环 | ((Z)-2-((3R,4R,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-(3-((tert-butyldiphenylsilyl) oxy)propoxy)-2-methylenecyclohexylidene)ethyl)diphenylphosphine oxide | 1254276-84-0 | C52H75O5PSi3 |
|
艾乐替尼中间体 | 2-(4-ethyl-3-iodophenyl)-2-methylpropionic acid | 1256584-73-2 | C12H15IO2 |
|
艾乐替尼中间体 | 6-cyano-2-{2-[4-ethyl-3-(4-(morpholin-4-yl)piperidin-1-yl)phenyl]propan-2-yl}-1H-indole-3-carboxylic acid | 1256584-78-7 | C30H36N4O3 |
|
色酮-3-甲醛 | 3-Formylchromone | 17422-74-1 | C10H6O3 |
|
色酮-3-甲腈 | 4-oxo-4H-1-benzopyran-3-carbonitrile | 50743-17-4 | C10H5NO2 |
|
色酮-2-甲酸 | acide chromone carboxylique-2 | 4940-39-0 | C10H6O4 |
|
色酚 AS-BI | 5-(2'-Hydroxy-3'-naphthoyl-amino)benzimidazol-2-one | 26848-40-8 | C18H13N3O3 |
|
色胺酮 | tryptanthrine | 13220-57-0 | C15H8N2O2 |
|
舒巴坦杂质19 | benzhydryl 2-[4-(2-benzothiazolyldithio)-2-oxoazetidinyl-1]-2-(isopropyl)acetate | 87579-79-1 | C28H24N2O3S3 |
|
膦酸,[2-(2-甲基-1,3-二噁戊环-2-基)-2-羰基乙基]-(9CI) | endo-Bicyclo<2,2,1>-hepten-(2)-carbonsaeure-(5)-methylester | 769-85-7 | C9H12O2 |
|
膦酸,[2-(2-甲基-1,3-二噁戊环-2-基)-2-羰基乙基]-(9CI) | methyl (1S,2R,4S)-bicyclo[2.2.1]hept-5-ene-2-carboxylate | 769-85-7 | C9H12O2 |
|
腺苷酰基-(3,’5’)-胞苷 | Cytidin-(3',5')-adenosin | 2382-66-3 | C19H25N8O11P |
|
腺苷酰-(3'→5')-胞苷 | Adenylyl cytidine | 4833-63-0 | C19H25N8O11P |
|
脱氢诺龙醋酸酯 | 6-dehydro-19-nortestosterone acetate | 2590-41-2 | C20H26O3 |
|
脯氨酰-甘氨酰-脯氨酰-肾上腺皮质激素 (4-7) | H-Met-Glu-His-Phe-Pro-Gly-Pro | 80714-61-0 | C37H51N9O10S |
|
胸苷酸 | thymidine 5'-phosphate | 365-07-1 | C10H15N2O8P |
|
胸腺嘧啶脱氧核苷-2-14C | 2-(14C)-thymidine | 13010-45-2 | C10H14N2O5 |
|
胸腺嘧啶-T | 1-[(2R,4S,5R)-4-hydroxy-5-(tritiooxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | 28854-96-8 | C10H14N2O5 |
|
胸腺嘧啶-1-乙酸 | thymidyl acetic acid | 20924-05-4 | C7H8N2O4 |
|
胸腺嘧啶 | Thymidine-methyl-T | 1148-63-6 | C10H14N2O5 |
|
胸腺嘧啶 | thymin | 65-71-4 | C5H6N2O2 |
|